IPS Examines How Uganda’s Anti-Counterfeit Bill Could Impact Access To Generic Drugs
According to the news service, Gagawala Wambuzi, Uganda's trade minister "who is spearheading the bill," recently defended the bill as a means of protecting the country's industry from counterfeiters, but he agreed the bill should not restrict the manufacturing or importation of generic drugs.
Still, groups are calling for the bill to be redrafted. Uganda's Registration Services Bureau, for instance, "believes the bill should be redrafted specifically only fill the gaps in the existing [intellectual property] legal frameworks in the Copyright Act and Trademarks Act," IPS writes, adding that similar counterfeit measures adopted in Kenya and Tanzania could threaten the production of generic medicines (Michael, 4/29).This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.